Literature DB >> 28030864

CD68-Positive Cells in Hepatic Angiomyolipoma.

Hitoshi Tochio1, Eriko Tamaki, Yukihiro Imai, Nobuhiro Iwasaki, Kazushi Minowa, Hobyung Chung, Yoshiki Suginoshita, Tetsurou Inokuma, Masatoshi Kudo.   

Abstract

Four resected specimens of hepatic angiomyolipoma in which uptake of Sonazoid was observed in the postvascular phase of Sonazoid-enhanced ultrasonography were analyzed. Macrophage localization in the tumor was revealed pathologically by immunohistochemical staining for CD68. CD68-positive cells were observed in the tumor in all cases. The density of CD68-positive cells was 100/mm2, and the ratio of CD68-positive cell density in the tumor to that in the surrounding parenchyma was 32-171%. These results suggested that the uptake of the contrast agent Sonazoid was related to the density of CD68-positive cells.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28030864     DOI: 10.1159/000451013

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  Hepatic Angiomyolipoma Staining in the Post-vascular Phase of Contrast-enhanced Ultrasound Due to the Presence of Macrophages.

Authors:  Kei Endo; Hidekatsu Kuroda; Keisuke Kakisaka; Takayoshi Oikawa; Kei Sawara; Kazuyuki Ishida; Tamotsu Sugai; Yasuhiro Takikawa
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

Review 2.  HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas.

Authors:  Jérôme R Lechien; Géraldine Descamps; Imelda Seminerio; Sonia Furgiuele; Didier Dequanter; Francois Mouawad; Cécile Badoual; Fabrice Journe; Sven Saussez
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

3.  Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment.

Authors:  Yan Tang; David J Kwiatkowski; Elizabeth P Henske
Journal:  Nat Commun       Date:  2022-08-26       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.